Covid has been allowed in the country. All necessary changes in the administration of heterologous precaution dose using Corbevax to those eligible and due for precaution dose have been made on the Co-WIN portal.
This provision would be live from August 12, Union Health Secretary Rajesh Bhushan said. Bhushan said that Corbevax will be available as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for populations above 18 years.
People can choose the existing homologous precaution dose or they can also opt for a heterologous precaution dose. As per the health secretary, the decision has been taken based on scientific evidence, global practices, and the recommendations of domain knowledge experts.
Covishield is produced for the Indian market by the Serum Institute of India under licence from AstraZeneca, while Bharat Biotech makes Covaxin.